INTRODUCTION: Women treated for breast cancer are at increased risk for developing second or new cancers. This study examined behavioral and health care utilization practices associated with screening behaviors for mammography, Papanicolaou (Pap), home fecal occult blood test (FOBT) and endoscopy (flexible sigmoidoscopy, colonoscopy, proctoscopy) among racially and ethnically diverse female breast cancer survivors (BCS) and women without a cancer history. METHODS: Data from the 2001 and 2003 California Health Interview Survey (CHIS), a random-digit dial population-based survey of adult respondents was used to examine self-reported screening practices of BCS (n = 1,502) and women without a cancer history (n = 31,911). RESULTS: Compared to women without a cancer history, BCS reported more recent screening for all tests. Among BCS, Hispanics reported lowest screening for routine mammography (84.2% versus 68.9%; P < 0.05) but highest screening for Pap test (95.4% versus 85.4%; P > 0.01). White and Asian BCS reported more endoscopic examinations (58.9% versus 46.5%; P < 0.001; 61.2% versus 38.4%; P < 0.05) than the comparison population. After adjustment for demographic, socioeconomic, and health status differences, screening rates for BCS showed higher mammography use (odds ratio [OR] 1.97; 95% confidence interval [95% CI] 1.58-2.46), Pap test (OR 1.44; 95% CI 1.22-1.70), and endoscopic use (OR 1.35; 95% CI 1.16-1.58), but not higher for FOBT. CONCLUSIONS: Even though BCS generally had higher cancer screening rates than women without a cancer history, racial/ethnic differences exist among the type of test received. Narrowing these differences is essential to lessen disparities. IMPLICATIONS FOR CANCER SURVIVORS: The need for screening guidelines for BCS remains a high priority. Survivors would benefit from the frequency of screening for all cancers post-treatment.
INTRODUCTION:Women treated for breast cancer are at increased risk for developing second or new cancers. This study examined behavioral and health care utilization practices associated with screening behaviors for mammography, Papanicolaou (Pap), home fecal occult blood test (FOBT) and endoscopy (flexible sigmoidoscopy, colonoscopy, proctoscopy) among racially and ethnically diverse female breast cancer survivors (BCS) and women without a cancer history. METHODS: Data from the 2001 and 2003 California Health Interview Survey (CHIS), a random-digit dial population-based survey of adult respondents was used to examine self-reported screening practices of BCS (n = 1,502) and women without a cancer history (n = 31,911). RESULTS: Compared to women without a cancer history, BCS reported more recent screening for all tests. Among BCS, Hispanics reported lowest screening for routine mammography (84.2% versus 68.9%; P < 0.05) but highest screening for Pap test (95.4% versus 85.4%; P > 0.01). White and Asian BCS reported more endoscopic examinations (58.9% versus 46.5%; P < 0.001; 61.2% versus 38.4%; P < 0.05) than the comparison population. After adjustment for demographic, socioeconomic, and health status differences, screening rates for BCS showed higher mammography use (odds ratio [OR] 1.97; 95% confidence interval [95% CI] 1.58-2.46), Pap test (OR 1.44; 95% CI 1.22-1.70), and endoscopic use (OR 1.35; 95% CI 1.16-1.58), but not higher for FOBT. CONCLUSIONS: Even though BCS generally had higher cancer screening rates than women without a cancer history, racial/ethnic differences exist among the type of test received. Narrowing these differences is essential to lessen disparities. IMPLICATIONS FOR CANCER SURVIVORS: The need for screening guidelines for BCS remains a high priority. Survivors would benefit from the frequency of screening for all cancers post-treatment.
Authors: Marjorie Kagawa-Singer; Nadereh Pourat; Nancy Breen; Steven Coughlin; Teresa Abend McLean; Timothy S McNeel; Ninez A Ponce Journal: Med Care Res Rev Date: 2007-09-05 Impact factor: 3.929
Authors: Israel De Alba; F Allan Hubbell; Juliet M McMullin; Jamie M Sweningson; Richard Saitz Journal: J Gen Intern Med Date: 2005-03 Impact factor: 5.128
Authors: T J Smith; N E Davidson; D V Schapira; E Grunfeld; H B Muss; V G Vogel; M R Somerfield Journal: J Clin Oncol Date: 1999-03 Impact factor: 44.544
Authors: Jeanne S Mandelblatt; William F Lawrence; Jennifer Cullen; Annette L Stanton; Janice L Krupnick; Lorna Kwan; Patricia A Ganz Journal: J Clin Oncol Date: 2006-01-01 Impact factor: 44.544
Authors: F E Alexander; T J Anderson; H K Brown; A P Forrest; W Hepburn; A E Kirkpatrick; B B Muir; R J Prescott; A Smith Journal: Lancet Date: 1999-06-05 Impact factor: 79.321
Authors: Su-Ying Liang; Kathryn A Phillips; Mika Nagamine; Uri Ladabaum; Jennifer S Haas Journal: Prev Chronic Dis Date: 2006-09-15 Impact factor: 2.830
Authors: Lacey Loomer; Kevin C Ward; Evelyn A Reynolds; Silke A von Esenwein; Joseph Lipscomb Journal: J Cancer Surviv Date: 2019-06-06 Impact factor: 4.442
Authors: Jasmin A Tiro; Joanne M Sanders; L Aubree Shay; Caitlin C Murphy; Heidi A Hamann; L Kay Bartholomew; Lara S Savas; Sally W Vernon Journal: Breast Cancer Res Treat Date: 2015-04-29 Impact factor: 4.872
Authors: Pragati S Advani; Jun Ying; Richard Theriault; Amal Melhem-Bertrand; Stacy Moulder; Isabelle Bedrosian; Welela Tereffe; Shon Black; Tunghi May Pini; Abenaa M Brewster Journal: Cancer Date: 2013-11-20 Impact factor: 6.860
Authors: Tracy Onega; Tor D Tosteson; Julie Weiss; Jennifer S Haas; Martha Goodrich; Roberta DiFlorio; Charles Brackett; Cheryl Clark; Kimberly Harris; Anna N A Tosteson Journal: J Gen Intern Med Date: 2018-08-03 Impact factor: 5.128
Authors: Melissa Y Carpentier; Jasmin A Tiro; Lara S Savas; L Kay Bartholomew; Trisha V Melhado; Sharon P Coan; Keith E Argenbright; Sally W Vernon Journal: J Cancer Surviv Date: 2012-12-18 Impact factor: 4.442
Authors: Andy S L Tan; Mihaela Moldovan-Johnson; Stacy W Gray; Robert C Hornik; Katrina Armstrong Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-11-01 Impact factor: 4.254
Authors: Pragati Advani; Shailesh Advani; Pratibha Nayak; Helena M VonVille; Pamela Diamond; Jason Burnett; Abenaa M Brewster; Sally W Vernon Journal: J Cancer Surviv Date: 2021-05-13 Impact factor: 4.442
Authors: Beth A Glenn; Narissa J Nonzee; Ann S Hamilton; Lina Tieu; Annette E Maxwell; Catherine M Crespi; L Cindy Chang; Dennis Deapen; Roshan Bastani Journal: J Cancer Surviv Date: 2020-08-14 Impact factor: 4.442